In March 2025, the company declared new strategies for just a immediate-to-consumer supplying of its Wegovy weight loss drug. The company recognized a brand new pharmacy, identified as NovoCare, which might charge shoppers $499 per month for access to the drug, less than 50 percent the cost of the drug via other pharmaceutical distribution networks